Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Isolates

about

Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Isolates

Item

http://www.wikidata.org/entity/Q57901772

description

scientific article published on 29 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Itraconazole, Voriconazole, an ...... e and Azole-Resistant Isolates

@en

Itraconazole, Voriconazole, an ...... e and Azole-Resistant Isolates

@nl

type

Item

label

Itraconazole, Voriconazole, an ...... e and Azole-Resistant Isolates

@en

Itraconazole, Voriconazole, an ...... e and Azole-Resistant Isolates

@nl

prefLabel

Itraconazole, Voriconazole, an ...... e and Azole-Resistant Isolates

@en

Itraconazole, Voriconazole, an ...... e and Azole-Resistant Isolates

@nl

P1476

Itraconazole, Voriconazole, an ...... Aspergillus fumigatus Isolates

@en

P2093

Jochem B Buil

http://www.w3.org/2001/XMLSchema#string

P2860

Sterol Biosynthesis and Azole Tolerance Is Governed by the Opposing Actions of SrbA and the CCAAT Binding Complex

Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing

Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.

Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.

A Novel Environmental Azole Resistance Mutation in Aspergillus fumigatus and a Possible Role of Sexual Reproduction in Its Emergence.

Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi.

First detection of Aspergillus fumigatus azole-resistant strain due to Cyp51A TR46/Y121F/T289A in an azole-naive patient in Spain.

Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009.

Posaconazole pharmacodynamic target determination against wild-type and Cyp51 mutant isolates of Aspergillus fumigatus in an in vivo model of invasive pulmonary aspergillosis

P304

103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/JOF4030103

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30158470

http://www.w3.org/2001/XMLSchema#string

P932

6162657

http://www.w3.org/2001/XMLSchema#string